We study biological clocks in ageing and age-related diseases
We utilize transgenic models, clinical samples and primary cells to investigate circadian clock changes (in vivo and in vitro) with ageing and in disease. Underpinning mechanisms identified will be targeted by pharmacological and genetic approaches. Outcomes could aid therapeutic drug design against age-related ailments.
Qing-Jun Meng is a Professor of Chronobiology and an Arthritis Research UK (ARUK; Versus Arthritis) Senior Research Fellow in the Faculty of Biology, Medicine and Health, the University of Manchester. He is also the Director of Internationalisation (School of Biological Sciences) and the Academic Lead of the Biosciences International Summer School (BIO-SISS).
Qing-Jun (MD and PhD) started his post-doctoral training in 2003 at the University of Manchester on the molecular mechanisms and pharmacological resetting of the biological clocks. In 2009, Qing-Jun was awarded a MRC Career Development Award Fellowship on clocks and age-related diseases. In 2015, he was awarded an ARUK Senior Research Fellowship to continue his work into the roles of circadian clocks in health and disease of the musculoskeletal system.